Clinical Trials Logo

Clinical Trial Summary

Levobupivacaïne (Chirocaine®) is a new local anaesthetic recently marketed in France. The goal of this prospective work is to study the pharmacokinetic aspect of this drug after injection around the sciatic nerve (subgluteal way).


Clinical Trial Description

The originality of this work is to call upon a modelling of pharmacokinetic by using the principle of the pharmacology of population.

This work also proposes to appreciate a dynamic aspect since data of effectiveness and tolerance will be collected with regular intervals during the first 24 hours after the beginning of the study. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms

  • Surgical Pathology of the Leg or the Foot.

NCT number NCT00682344
Study type Interventional
Source Assistance Publique Hopitaux De Marseille
Contact
Status Terminated
Phase Phase 3
Start date January 2008
Completion date January 2012